HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tae-You Kim Selected Research

SK-7068

1/2008Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase.
8/2004Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tae-You Kim Research Topics

Disease

138Neoplasms (Cancer)
04/2022 - 01/2003
53Stomach Neoplasms (Stomach Cancer)
01/2019 - 01/2003
50Breast Neoplasms (Breast Cancer)
01/2020 - 03/2004
39Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 10/2005
29Neoplasm Metastasis (Metastasis)
12/2021 - 04/2004
24Hepatocellular Carcinoma (Hepatoma)
04/2022 - 03/2005
22Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2014 - 06/2002
14Adenocarcinoma
01/2016 - 11/2004
13Colonic Neoplasms (Colon Cancer)
03/2022 - 07/2010
11Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2017 - 01/2008
10Microsatellite Instability
01/2021 - 07/2011
10Rectal Neoplasms (Rectal Cancer)
01/2021 - 12/2013
9Carcinogenesis
12/2017 - 04/2004
9Carcinoma (Carcinomatosis)
10/2010 - 02/2004
8Disease Progression
01/2022 - 01/2008
8Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 10/2011
7Triple Negative Breast Neoplasms
07/2017 - 11/2007
7Lung Neoplasms (Lung Cancer)
01/2015 - 11/2007
6Nausea
01/2019 - 02/2009
6Hypoxia (Hypoxemia)
07/2013 - 02/2002
5Vomiting
01/2019 - 12/2004
4Infections
01/2019 - 05/2002
4Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2018 - 01/2009
3Fatigue
01/2021 - 10/2014
3Margins of Excision
07/2019 - 12/2013
3Neutropenia
01/2019 - 10/2014
3Obesity
10/2017 - 12/2012
3Thrombocytopenia (Thrombopenia)
07/2016 - 12/2013
3Weight Loss (Weight Reduction)
04/2016 - 06/2002

Drug/Important Bio-Agent (IBA)

27Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 01/2003
21Cisplatin (Platino)FDA LinkGeneric
10/2021 - 11/2002
17DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2004
17Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2019 - 05/2008
16Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2011
16Proteins (Proteins, Gene)FDA Link
09/2017 - 01/2003
16ErbB Receptors (EGF Receptor)IBA
10/2015 - 01/2005
14Sorafenib (BAY 43-9006)FDA Link
04/2022 - 04/2011
14Trastuzumab (Herceptin)FDA Link
10/2019 - 01/2008
13Doxorubicin (Adriamycin)FDA LinkGeneric
01/2015 - 12/2003
11GemcitabineFDA Link
10/2021 - 06/2006
11Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 01/2003
11Tyrosine Kinase InhibitorsIBA
07/2018 - 11/2007
11PlatinumIBA
01/2018 - 01/2005
10Lapatinib (GW572016)FDA Link
10/2019 - 03/2008
10Histone Deacetylase InhibitorsIBA
12/2018 - 03/2004
10Biological ProductsIBA
03/2017 - 09/2004
10Gefitinib (Iressa)FDA Link
02/2012 - 01/2005
9Pharmaceutical PreparationsIBA
01/2022 - 06/2004
9Leucovorin (Folinic Acid)FDA Link
07/2016 - 05/2008
9human ERBB2 proteinIBA
12/2013 - 10/2008
8Irinotecan (Camptosar)FDA LinkGeneric
10/2021 - 09/2008
8Hormones (Hormone)IBA
01/2020 - 02/2010
8Estrogen ReceptorsIBA
12/2015 - 03/2004
8Docetaxel (Taxotere)FDA Link
01/2015 - 07/2005
7Calcibiotic Root Canal SealerIBA
01/2021 - 07/2011
7Capecitabine (Xeloda)FDA Link
03/2019 - 01/2011
7MethyltransferasesIBA
04/2016 - 04/2004
7Histones (Histone)IBA
07/2012 - 08/2005
6taxaneIBA
12/2017 - 06/2008
5Bevacizumab (Avastin)FDA Link
04/2022 - 02/2013
5Cetuximab (Erbitux)FDA Link
01/2022 - 03/2008
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 - 09/2009
5NivolumabIBA
11/2020 - 06/2017
5regorafenibIBA
01/2020 - 01/2015
5Messenger RNA (mRNA)IBA
10/2019 - 02/2002
5ChromatinIBA
12/2017 - 07/2013
5Thymidylate SynthaseIBA
07/2011 - 12/2006
5Histone Deacetylases (Histone Deacetylase)IBA
08/2010 - 12/2003
5Transforming Growth Factor beta1 (TGF beta 1)IBA
08/2005 - 02/2004
4thiamine triphosphorate (TTP)IBA
01/2018 - 08/2010
4Methotrexate (Mexate)FDA LinkGeneric
12/2017 - 12/2003
4AnthracyclinesIBA
12/2017 - 08/2005
4CytokinesIBA
03/2017 - 12/2007
4hydrogen sulfite (bisulfite)IBA
04/2016 - 04/2004
4Epidermal Growth Factor (EGF)IBA
11/2013 - 11/2006
3atezolizumabIBA
04/2022 - 01/2020
3Circulating Tumor DNAIBA
11/2021 - 01/2020
3Cell-Free Nucleic AcidsIBA
11/2021 - 01/2020
3RamucirumabIBA
11/2021 - 10/2014
3Monoclonal AntibodiesIBA
01/2021 - 08/2012
3B7-H1 AntigenIBA
01/2021 - 11/2016
3Carcinoembryonic AntigenIBA
01/2020 - 07/2017
3MucinsIBA
07/2019 - 09/2015
3RNA (Ribonucleic Acid)IBA
01/2019 - 10/2007
3HM781-36BIBA
07/2018 - 03/2011
3CohesinsIBA
12/2017 - 01/2016
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2017 - 04/2007
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2016 - 12/2008
3Phenobarbital (Luminal)FDA Link
01/2016 - 12/2013
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2016 - 05/2011

Therapy/Procedure

87Drug Therapy (Chemotherapy)
01/2022 - 11/2002
45Therapeutics
01/2022 - 12/2003
22Neoadjuvant Therapy
01/2021 - 11/2004
19Radiotherapy
04/2022 - 06/2002
19Adjuvant Chemotherapy
03/2022 - 12/2004
14Chemoradiotherapy
10/2021 - 06/2002
12Adjuvant Chemoradiotherapy
04/2017 - 02/2009
12Combination Drug Therapy (Combination Chemotherapy)
09/2014 - 01/2003
3Adjuvant Radiotherapy
01/2016 - 07/2010
3Salvage Therapy
10/2015 - 02/2010